HEALTH AND ECONOMIC BURDEN OF INTERSTITIAL LUNG DISEASES
RESEARCHER PROFILE (Filmed April 2024)
Dr Ingrid Cox
Postdoctoral Research Fellow
Menzies Institute for Medical Research
University of Tasmania
Dr Ingrid Cox is a Postdoctoral Research Fellow at the Menzies Institute for Medical Research, University of Tasmania. She is a physician and health economist by training and has extensive experience working in healthcare, including in clinical practice, public health, health policy and health planning, and has worked with regional governmental agencies in the Caribbean and international development partners working in health.
Dr Cox’s main research interests focus on respiratory diseases and primarily on the economic burden and economic evaluation of interventions and treatments for their management. She earned her PhD from the University of Tasmania where her doctoral research examined the health and economic burden of idiopathic pulmonary fibrosis (IPF) in Australia, one component of the NHMRC Centre for Research Excellence for Pulmonary Fibrosis, a national project implemented alongside the Australian IPF Registry and the Lung Foundation Australia. This research provided the first epidemiological profile and first costing estimates of the economic burden of the disease in Australia, providing essential evidence for health service reimbursement policies.
Dr Cos completed her PhD in 2022 and since then has been the recipient of two Fellowships, the first the Menzies Postdoctoral Fellowship and the second a Fellowship with Lung Foundation Australia.
Currently Dr Cox’s research work spans several areas including her continued work on IPF and other interstitial lung diseases on several national projects, health services research including some work with the Royal Flying Doctor Service, prostate cancer research and her current lung cancer research funded by the major project grant of the Royal Hobart Hospital Research Foundation.
Dr Cox holds executive committee positions on the Australian Health Economics Society, the Professional Society or Health Economics and Outcomes Research both nationally and internationally, is currently the President of the Thoracic Society of Australia and New Zealand Tasmanian Branch and Chair of the Lung Cancer Special Interest Group.
Source: Supplied, Centre Of Research Excellence In Pulmonary Fibrosis
You Might also like
-
Stem cells used for age-related macular degeneration
Dr. Jenna Hall is a passionate and accomplished biologist with expertise in induced pluripotent stem cell (iPSC) culture, disease modelling, and high-throughput automated systems. She recently earned her PhD from the University of Melbourne, where her research focused on using iPSC-derived retinal pigment epithelium (RPE) cells to study age-related macular degeneration. Dr Hall’s technical skillset spans manual and automated cell reprogramming and differentiation, quantitative microscopy-based phenotyping, and large scale -omics analysis.
-
CASE STUDY Role of Exercise in Metabolic Associated Fatty Liver Disease
Dr. Shelley Keating AES AEP* is an Accredited Exercise Physiologist, a researcher, and a senior lecturer at the School of Human Movement and Nutrition Sciences at the University of Queensland in Brisbane, Australia. Dr. Keating’s research primarily focuses on the role of exercise in the management of metabolic dysfunction associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease. MASLD affects a significant portion of the global adult population, with many individuals unaware of their condition.
-
Dr Zarina Greenberg
RESEARCH IN SANFILIPPO
@ SAHMRI
ADELAIDE, SOUTH AUSTRALIA, AUSTRALIA